Jiangsu Yahong Meditech Co., Ltd. (SHA:688176)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Pharmaceuticals	277.12M	201.56M	13.75M	26.10K	4.57K
Pharmaceuticals Growth	37.49%	1365.55%	52604.90%	470.51%	-
Total	277.12M	201.56M	13.75M	26.10K	4.57K
Total Growth	37.49%	1365.55%	52604.90%	470.51%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
China	277.12M	201.56M	13.75M	26.10K	4.57K
China Growth	37.49%	1365.55%	52604.90%	470.51%	-
Total	277.12M	201.56M	13.75M	26.10K	4.57K
Total Growth	37.49%	1365.55%	52604.90%	470.51%	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 1, 2026

Data Sources Report a data error